ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
12.88
-0.01 (-0.08%)
Sep 16, 2026, 4:00 PM EDT - Market closed
ProMIS Neurosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 53.43 | 6.12 | 13.29 | 12.6 | 5.88 | 16.94 |
Short-Term Investments | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
Cash & Short-Term Investments | 53.46 | 6.15 | 13.32 | 12.63 | 5.92 | 16.98 |
Cash Growth | 1076.78% | -53.84% | 5.49% | 113.36% | -65.14% | 1857.25% |
Other Receivables | 0.22 | 0.04 | 0.08 | 0.08 | 0.07 | 0.05 |
Receivables | 0.22 | 0.04 | 0.08 | 0.08 | 0.07 | 0.05 |
Prepaid Expenses | 0.13 | 0.3 | 0.37 | 0.53 | 0.56 | 0.12 |
Other Current Assets | 2.89 | 2.7 | 5.13 | 0.38 | 0.35 | 0.56 |
Total Current Assets | 56.69 | 9.18 | 18.91 | 13.62 | 6.9 | 17.71 |
Property, Plant & Equipment | - | - | - | - | 0 | 0 |
Other Intangible Assets | - | - | - | - | 0.02 | 0.03 |
Total Assets | 56.69 | 9.18 | 18.91 | 13.62 | 6.92 | 17.75 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.79 | 2.54 | 1.74 | 7.84 | 2.98 | 0.41 |
Accrued Expenses | 5.42 | 7.87 | 0.48 | 1.51 | 3.44 | 0.52 |
Total Current Liabilities | 7.22 | 10.41 | 2.22 | 9.35 | 6.41 | 0.93 |
Long-Term Debt | - | - | - | - | - | 3.91 |
Other Long-Term Liabilities | 0.08 | 0.03 | 0.2 | 0.52 | 1.86 | 7.25 |
Total Liabilities | 7.29 | 10.44 | 2.42 | 9.87 | 8.27 | 12.09 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Additional Paid-In Capital | 200.15 | 129.52 | 107.55 | 97.59 | 79.1 | 68.04 |
Retained Earnings | -150.38 | -130.41 | -90.69 | -93.47 | -80.25 | -62.19 |
Comprehensive Income & Other | -0.37 | -0.37 | -0.37 | -0.37 | -0.2 | -0.19 |
Shareholders' Equity | 49.4 | -1.26 | 16.49 | 3.75 | -1.35 | 5.66 |
Total Liabilities & Equity | 56.69 | 9.18 | 18.91 | 13.62 | 6.92 | 17.75 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | - | 3.91 |
Net Cash (Debt) | 53.46 | 6.15 | 13.32 | 12.63 | 5.92 | 13.08 |
Net Cash Growth | 1076.78% | -53.84% | 5.49% | 113.36% | -54.73% | 1407.11% |
Net Cash Per Share | 10.70 | 3.50 | 12.59 | 25.69 | 19.73 | 56.51 |
Filing Date Shares Outstanding | 8.97 | 8.97 | 1.31 | 0.76 | 0.34 | 0.29 |
Total Common Shares Outstanding | 8.97 | 2.15 | 1.31 | 0.76 | 0.34 | 0.29 |
Working Capital | 49.48 | -1.23 | 16.69 | 4.27 | 0.49 | 16.79 |
Book Value Per Share | 5.51 | -0.58 | 12.61 | 4.97 | -3.93 | 19.67 |
Tangible Book Value | 49.4 | -1.26 | 16.49 | 3.75 | -1.37 | 5.63 |
Tangible Book Value Per Share | 5.51 | -0.58 | 12.61 | 4.97 | -3.99 | 19.57 |
Machinery | - | - | - | - | - | 0.08 |